Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May warrant considering percutaneous alternatives before surgery in heart failure; leaves open comparative effectiveness trials.
Themedia frenzy after one of the national cardiologymeetings is always interesting to observe. The late-breaking trials of pharmacology, drug-eluting coro-narystents,andpercutaneousheartvalvesconspiretomakeeventhebusiestcardiothoracicsurgeonthinkofhis or her own professional future. But amid our car-diologic colleagues’ excitement over the “vanishingscalpel”
No takes yet. Share an insight, caveat, or question.
Selzman et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: